Half-year report · HY
2931.TEDINET S100YVGZ
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥50.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥909m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥73m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥805m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥559m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥888m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥133m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥69.3bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥72.3bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥69.1bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.7bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.8bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.6bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥28.5bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥31.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.2bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥674m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥585m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥514m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.9bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.53 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.9 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.1 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.52 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.8% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥805m |
| Biofuel Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥160m |
| Health Care Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥3.0bn |
| Others Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Others Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥202m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥790m |
| Biofuel Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥114m |
| Health Care Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.8bn |
| Others Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥7m |
| Others Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥218m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 632
| Item | Context | Value | Unit |
|---|---|---|---|
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithFullVotingRightsOtherMember | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社ユーグレナ | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都港区芝5-29-11 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |